These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3889253)

  • 61. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
    de Lalla F
    Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Antibiotic therapy of febrile neutropenic patients: prospective study at a hematologic department].
    Limat S; Cornette C; Deconinck E; Woronoff-Lemsi MC; Cahn JY
    Presse Med; 1999 Apr; 28(14):729-33. PubMed ID: 10230408
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital.
    Bodey GP
    Rev Infect Dis; 1989; 11 Suppl 7():S1582-90. PubMed ID: 2690296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Penicillin and aminoglycoside in febrile neutropenia].
    Torfoss D; Høiby EA; Holte H; Kvaløy S
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2738-40. PubMed ID: 19079423
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy.
    Donnelly JP; Novakova IR; Raemaekers JM; De Pauw BE
    Leuk Lymphoma; 1993 Feb; 9(3):193-203. PubMed ID: 8471978
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.
    Torfoss D; Høiby EA; Tangen JM; Holte H; Bø K; Meyer P; Grøttum K; Weyde K; Lauritzsen GF; Sandstad B; Jacobsen AB; Olsen H; Kvaløy S
    J Antimicrob Chemother; 2007 Apr; 59(4):711-7. PubMed ID: 17327294
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gentamicin and low dose piperacillin in febrile neutropenic patients.
    Boughton BJ; Harris RI; Brown RM; Webberley J; Baglin TP; Jackson N; Girling AJ
    J Antimicrob Chemother; 1989 Jul; 24(1):45-51. PubMed ID: 2777728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Empirical antibiotic therapy for febrile neutropenia].
    Kridel R; Van Delden C; Calandra T; Marchetti O
    Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunocompromised animal models for the study of antibiotic combinations.
    Calandra T; Glauser MP
    Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of neutropenic infection: trends towards monotherapy?
    Klastersky J
    Support Care Cancer; 1997 Sep; 5(5):365-70. PubMed ID: 9322347
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
    Paul M; Yahav D; Fraser A; Leibovici L
    J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    Marty M; Gisselbrecht C; Samson-Lepors MJ
    Nouv Presse Med; 1979 Oct; 8(42):3465-8. PubMed ID: 537897
    [No Abstract]   [Full Text] [Related]  

  • 80. [Management of febrile neutropenic patients].
    Takata T; Tamura K
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):13-8. PubMed ID: 16410691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.